Inhibitors of Cytochrome P-450s and Their Mechanism of Action

Testa B., Jenner P. Drug Metabolism; Chemical and Biochemical Aspects. Marcel Dekker, New York 1976; 357–358

Ullrich V., 1977, Microsomes and Drug Oxidation

Coon M. J., 1980, Microsomes, Drug Oxidations, and Chemical Carcinogenesis, 1

10.3109/00498257409062539

Pannatier A., Effect of topically applied phenobarbital on mouse skin O-dealkylase activity and cytochrome P-450

Cinti D. L, 1978, Pharmacol. Ther. A., 2, 727

Mannering G. J, 1981, Concepts in Drug Metabolism, 53

Traylor T. G., 1979, Acta Biol. Med. Germ., 38, 351

10.1021/ja00847a046

Jung C., 1979, Acta Biol. Med. Germ., 38, 363

10.1073/pnas.73.10.3333

Gorrod J. W, 1978, Mechanism of Oxidizing Enzymes, 189

Conney A. H., 1968, J. Biol. Chem., 243, 3912, 10.1016/S0021-9258(18)92030-2

10.1016/0303-7207(76)90010-1

10.1016/0006-2952(77)90323-9

Nambara S., 1975, J. Pharm. Soc. Jap., 95, 1302, 10.1248/yakushi1947.95.11_1302

Ullrich V. The mechanism of cytochrome P-450 action. 192–201, In ref. 2

10.1016/0014-5793(79)81325-3

10.1016/0003-9861(75)90463-4

Imai Y., 1968, J. Biochem., 63, 380, 10.1093/oxfordjournals.jbchem.a128763

10.1016/0006-291X(66)90643-7

Nebert D. W., Kumaki K., Sato M., Kon H. Association of type I, type II, and reverse type I difference spectra with absolute spin state of cytochrome P-450 iron. 224–231, in Ref, 2

10.1254/jjp.27.601

10.1021/jm00176a006

10.1016/0006-2952(79)90371-X

Duthu G. S., 1979, Drug. Metab. Dispos., 7, 263

10.3109/00498257809070019

10.1159/000136865

10.1016/S0162-0134(00)80017-3

10.1016/0006-2952(76)90223-9

10.1016/0006-2952(79)90169-2

10.1016/0009-2797(79)90064-4

Wollenberg P., Ullrich V. Characterization of the drug monooxygenase system in mouse small intestine. 675–679, in Ref. 2

Cohen G. M., 1973, Molec. Pharmacol., 8, 383

10.1016/0009-2797(81)90101-0

10.1016/0009-2797(76)90061-2

10.1016/0009-2797(78)90048-0

10.1007/BF00343274

10.1016/0006-2952(79)90540-9

10.1016/0306-3623(76)90023-9

Wattenberg L. W., 1979, Cancer Res., 39, 1651

Kramer R. E., 1979, J. Pharmacol. Exp. Ther., 208, 19

Orrenius S., Moldeus P., Thor H., Hogberg J. The physiological implications of drug oxidations to the cell. 292–306, in Ref. 2

Rahimtula A. D., O'Brien P. J. The peroxidase nature of cytochrome P-450. 210–217, in Ref. 2

DiGiovanni J., 1977, Drug Metab. Dispos., 5, 295

10.1002/jps.2600641203

Thakker D. R., 1979, Molec. Pharmacol., 15, 138

10.1021/jm00219a017

10.1016/0006-2952(74)90598-X

10.1016/0024-3205(74)90124-6

Rahimtula A. D., 1979, Cancer Biochem. Biophys., 4, 9

10.1007/978-3-642-66896-8_8

Shen A. L., 1979, Cancer Res., 39, 4123

Mailman R. B., 1974, Drug Metab. Dispos., 2, 301

10.1016/0006-2952(74)90334-7

Mull R., Hinkelbein W., Gertz J., Flemming K. A preliminary comparative study on the influence of cysteamine and metyrapone on mixed-function oxydase activities in variously pretreated liver microsomes from rats and mice. 354–361, in Ref. 2

10.1002/jps.2600690728

Kahl R, Bücker M., Netter K. J. Sex differences in the pattern of cytochromes P-450 in rat liver microsomes. 177–184, in Ref. 2

Bücker M., 1979, Molec. Pharmacol., 16, 656

10.1016/0006-291X(78)91361-X

10.1016/0022-4731(77)90295-3

10.1021/jm00216a005

Gregotti C., 1979, Farmaco Ed. Prat., 34, 474

Mannering G. J, 1971, Fundamentals of Drug Metabolism and Drug Disposition, 206

Leibmann K. C., 1973, Drug Metab. Dispos., 1, 184

10.1016/0006-2952(72)90147-5

10.1016/0048-3575(74)90113-8

10.3109/00498257609151609

10.1016/0006-2952(74)90227-5

10.1016/0006-2952(78)90125-9

10.1042/bst0030970

10.1016/0006-291X(78)90643-5

10.1016/0006-2952(78)90363-5

10.1016/S0300-9084(78)80588-4

10.1016/0009-2797(79)90007-3

10.1016/0006-2952(80)90249-X

Goujon F. M., 1972, Molec. Pharmacol., 8, 667

10.1002/cpt1977224475

Burke M. D., 1977, Drug Metab. Dispos., 5, 1

10.1016/0006-2952(79)90507-0

Johnson E. F., 1979, Molec. Pharmacol., 15, 708

10.1016/0009-2797(75)90013-7

10.1021/jm00196a018

Franklin M. R, 1977, Pharmacol. Ther. A, 2, 227

10.3109/03602537408993744

10.1016/0041-008X(70)90022-0

10.1016/0006-291X(78)91108-7

Friedman M. A., 1977, Res. Commun. Chem. Pathol. Pharmacol., 17, 623

Ullrich V., 1973, Drug Metab. Dispos., 1, 176

Mansuy D, 1979, Mises au Point de Biochimie Pharmacologique, 123

10.1007/978-3-642-66896-8_8

10.1016/0006-2952(79)90447-7

10.1016/0009-2797(79)90123-6

10.3109/00498257909038724

10.3109/03602537808993771

10.1016/0006-2952(72)90389-9

Jonsson J., 1976, Acta Pharm. Suec., 13, 313

10.1016/0006-2952(79)90239-9

10.1016/0006-2952(76)90398-1

10.1016/S0300-9084(78)80583-5

Franklin M. R. The inhibition of mixed-function oxidation reactions by amphetamines in liver and lung microsomes. 284–291, in Ref. 2

Gal J., 1976, Res. Commun. Chem. Pathol. Pharmacol., 15, 525

10.3109/00498257309151497

10.1016/0006-2952(78)90456-2

10.3109/03602537708993765

10.3109/00498257909042320

10.1016/0006-2952(72)90004-4

10.1111/j.1749-6632.1971.tb46890.x

10.1002/cpt1973144part2727

Buening M. K., 1976, Drug Metab. Dispos., 4, 244

10.1016/0041-008X(78)90077-7

10.1016/0009-2797(76)90112-5

Bast A., 1980, Brit. J. Pharmacol., 68, 121P

10.1111/j.1432-1033.1978.tb12341.x

10.1021/jm00223a034

10.1016/0304-4165(78)90222-2

10.1016/0009-2797(79)90111-X

10.1016/0006-2952(75)90344-5

10.1254/jjp.19.315

Prough R. A., Coomes M. L., Dunn D. L. The microsomal metabolism of carcinogenic and/or therapeutic hydrazines. 500–507, in Ref. 2

Hines R. N., 1980, J. Pharmacol. Exp. Ther., 214, 80

10.1016/0163-7258(80)90029-7

10.3109/00498257609151673

Davis D. C., 1971, J. Pharmacol. Exp. Ther., 177, 556

10.1111/j.1600-0773.1980.tb02416.x

10.1016/0006-291X(75)90121-7

10.1254/jjp.29.715

10.1016/S0031-6989(78)80061-7

10.1042/bj1840481

10.1016/0014-5793(80)81180-X

Wolf C. R., 1977, Mol. Pharmacol., 13, 698

10.1016/S0006-291X(80)80072-6

10.1016/0024-3205(77)90446-5

10.1016/0006-2952(79)90255-7

10.1016/0041-008X(74)90068-4

10.1016/0006-2952(69)90299-8

Martz F., 1976, Res. Commun. Chem. Pathol. Pharmacol., 13, 83

Reynolds E. S., 1975, Res. Commun. Chem. Pathol. Pharmacol., 12, 685

10.1016/0041-008X(79)90260-6

Guenge rich F. P., 1977, Mol. Pharmacol., 13, 993

Levin W., 1973, Drug Metab. Dispos., 1, 275

De Matteis F, 1973, Drug Metab. Dispos., 1, 267

10.1016/0009-2797(76)90104-6

Ortiz de Montellano P. R., 1978, Enzyme-activated Irreversible Inhibitors, 337

10.1016/0003-9861(79)90276-5

10.1016/0006-291X(78)90407-2

10.1042/bj1830099

10.1016/S0040-4039(00)74569-2

Ortiz de Montellano P. R., 1980, Mol. Pharmacol., 18, 128

Ivanetich K. M., 1978, Drug Metab. Dispos., 6, 218

10.1016/0006-291X(80)91251-6

10.1042/bj1740853

Sullivan H. R., 1979, Drug Metab. Dispos., 7, 76

10.1042/bj1840509

10.1042/bj1880867

10.1073/pnas.76.2.746

Ortiz de Montellano P. R., 1980, J. Biol. Chem., 255, 5578, 10.1016/S0021-9258(19)70669-3

10.1002/jps.2600670927

10.1021/jm00193a002

Neal R. A., Kamataki T., Hunter A. L., Catignani G. Monooxygenase catalyzed activation of thiono-sulfur containing compounds to reactive intermediates. 467–475, in Ref. 2

Testa B., Jenner P. Drug Metabolism; Chemical and Biochemical Aspects. Marcel Dekker, New York 1976; 112–113

10.1016/0006-2952(78)90494-X

Davis J. E., 1977, J. Pharmacol. Exp. Ther., 201, 490

Kamataki T., 1976, Mol. Pharmacol., 12, 933

Halpert J., 1980, J. Biol. Chem., 255, 1080, 10.1016/S0021-9258(19)86145-8

De Matteis F, 1974, Mol. Pharmacol., 10, 849

Lee P. W., 1978, Drug Metab. Dispos., 6, 591

10.1111/j.1600-0773.1977.tb02085.x

Jarvisalo J., 1978, Mol. Pharmacol., 14, 1099

10.1016/0006-2952(75)90052-0

10.1016/0041-008X(79)90041-3

Freundt K. J, 1978, Int. J. Clin. Pharmacol. Biopharm., 16, 323

10.1007/BF00606562

Marselos M., Alakuijala P., Lang M., Torronen R. Studies on the mechanism by which disulfiram and diethyldi-thiocarbamate affect drug metabolism. 589–596, in Ref. 2

10.1016/0041-008X(79)90428-9

Menard R. H., 1979, Mol. Pharmacol., 16, 997

Jeffery E., 1977, Mol. Pharmacol., 13, 415

Jeffery E. H., Nerland D., el Azhary R., Mannering G. J. Destruction of cytochrome P-450 by linoleic acid hydroperoxide. 323–330, in Ref. 2

10.1016/0006-291X(76)90646-X

10.1016/0041-008X(79)90040-1

10.1016/0014-5793(79)80070-8

Halpert J., 1980, Mol. Pharmacol., 17, 427

10.1016/0006-2952(78)90383-0

10.1016/0006-2952(79)90004-2

Thomas P. E., 1977, Mol. Pharmacol., 819

Kaminsky L. S., 1980, J. Biol. Chem., 255, 85, 10.1016/S0021-9258(19)86267-1

Maines M. D. The mechanism of degradation of endogenous heme and cytochrome P-450 by heme oxygenase. 543–550, in Ref. 2

Eiseman J. L., 1978, Mol. Pharmacol., 14, 1176

Sasame H. A., 1978, J. Pharmacol. Exp. Ther., 205, 718

10.3109/03602537908993893

Sinclair P., 1979, Bio-chem. J., 178, 529

10.1007/BF00310332

10.1016/0041-008X(79)90024-3

Moldowan M. J., 1979, Res. Commun. Chem. Pathol. Pharmacol., 25, 343

10.3109/03602537908993902

10.1016/0041-008X(79)90036-X

10.1042/bj1900465

10.1254/jjp.17.56

Belanger P. M., 1979, J. Pharmacol. Exp. Ther., 211, 485

10.1016/0006-291X(76)90713-0

el Azhary R., 1980, Mol. Pharmacol., 17, 395

Barnes D. W., 1979, J. Pharmacol. Exp. Ther., 208, 392

Gelboin H. V. Mechanisms of induction of drug metabolism enzymes, in Fundamental of Drug Metabolism and Drug Disposition, B. N. La Du, H. G. Mandel, E. L. Way. Williams & Wilkins, Baltimore 1972; 279–307

10.1073/pnas.73.7.2501

10.1111/j.1476-5381.1977.tb16751.x

Borowsky S. A., 1978, J. Pharmacol. Exp. Ther., 207, 123

Perrin L., 1973, Schweiz. Rundschau Med. (Praxis), 62, 846

Stockley I, 1974, Drug Interactions and Their Mechanisms

Skovsted L., 1974, Drug Interactions, 81

10.1111/j.1528-1157.1975.tb06065.x

10.2165/00003088-197601050-00003

Egli M, 1977, Schweiz. Med. Wochenschr., 107, 1513

Greim H, Concepts in Drug Metabolism

10.1007/BF01059791

Rowland M, 1977, Drug Metabolism; From Microbe to Man, 123

10.1016/S0140-6736(79)90340-4

10.1016/S0140-6736(79)92104-4

10.1007/BF00561588

10.1002/cpt1979252196

10.1111/j.1365-2125.1975.tb01589.x

10.1002/cpt1975176731

Kristensen M, 1973, Medikament-medikament interaktion

Dubach U. C., 1966, Schweiz. Med. Wochenschr., 96, 1483

Kristensen M, 1969, Acta Diabetol. Lat., Suppl., 6, 116

10.1002/cpt1971125785

10.1002/cpt1976206661

Richens A, 1974, Proc. Royal Soc. Med., 67, 1227, 10.1177/003591577406712P115

Ashley J. J., 1972, Res. Commun. Chem. Path. Pharmacol., 4, 297

10.1007/BF01059624

10.1016/S0140-6736(69)90937-4

Solomon H. M, 1964, J. Pharmacol. Exp. Ther., 154, 660

10.1016/0006-2952(70)90123-1

Goldstein M., 1979, Res. Commun. Chem. Path. Pharmacol., 23, 203

10.1016/0378-4274(79)90048-1

Siegers C. P., 1979, Arzneim. -Forsch., 29, 520

Mitchell J. R., 1973, J. Pharmacol. Exp. Ther., 187, 185